Patents Assigned to Triplet Therapeutics, Inc.
  • METHODS FOR THE TREATMENT OF TRINUCLEOTIDE REPEAT EXAPNSION DISORDERS ASSOCIATED WITH OGG1 ACTIVITY
    Publication number: 20230041178
    Abstract: The present disclosure features useful compositions and methods to treat trinucleotide repeat expansion disorders, e.g., in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with OGG1 activity.
    Type: Application
    Filed: December 2, 2019
    Publication date: February 9, 2023
    Applicant: Triplet Therapeutics, Inc.
    Inventors: Nessan Anthony BERMINGHAM, Brian R. BETTENCOURT, Peter Edward BIALEK
  • Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity
    Patent number: 11408000
    Abstract: The present disclosure features useful compositions and methods to treat nucleotide repeat expansion disorders, e.g., in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with MSH3 activity.
    Type: Grant
    Filed: June 2, 2021
    Date of Patent: August 9, 2022
    Assignee: Triplet Therapeutics, Inc.
    Inventors: Nessan Anthony Bermingham, Brian R. Bettencourt, Pei Ge